文献速递心力衰竭与心肌病心律失常

非扩张型左心室心肌病的CMR表型分层与预后价值

Phenotypic stratification and prognostic value of cardiac magnetic resonance in non-dilated left ventricular cardiomyopathy.
PubMed 文献 · Heart · 2026-01-09

研究纳入515例非扩张型左心室心肌病(NDLVC)患者,按心脏磁共振(CMR)分为LGE+/H-、LGE-/H+和LGE+/H+三种表型,随访6.5年。LGE+/H+组复合终点风险最高,LGE范围是独立预测因子,支持将CMR表型用于风险分层。

要点

  • CMR可对NDLVC进行表型分层,LGE+/H+表型预后最差。
  • LGE范围独立预测全因死亡/心脏移植和心衰事件。
  • 即使LVEF保留,LGE范围仍可识别高危患者。

核心结论

  • CMR表型分层可实现NDLVC的风险分层,LGE+/H+表型复合终点风险最高。
  • LGE范围是独立预测因子,有助于识别高危患者,即使射血分数保留。

研究设计与样本

  • 回顾性队列研究,纳入515例NDLVC患者,平均年龄45(16)岁。
  • 按CMR分为三组:LGE+/H-(n=130)、LGE-/H+(n=226)、LGE+/H+(n=159)。
  • 主要终点为全因死亡/心脏移植,次要终点包括心衰事件和恶性室性心律失常。

主要发现

  • 平均随访6.5(1.9)年,29例(5.6%)达到主要终点,81例(15.7%)发生心衰,19例(3.7%)发生恶性室性心律失常。
  • LGE+/H+组复合临床终点风险显著高于其他表型组(p<0.001)。
  • 多变量分析中,NYHA分级>II(HR 3.42,95%CI 1.58-7.39,p=0.002)、LVEF(每增加1%,HR 0.91,95%CI 0.88-0.95,p<0.001)和LGE范围(每增加3%,HR 1.14,95%CI 1.07-1.21,p<0.001)为独立预测因子,C统计量0.862。
  • 校正模型中,LGE范围独立预测心衰(每增加3%,HR 1.11,95%CI 1.06-1.17,p<0.001)。
  • 单变量Cox回归显示LGE范围与恶性室性心律失常显著相关(每增加3%,HR 1.12,95%CI 1.02-1.23,p=0.021)。

临床怎么用

  • 对NDLVC患者行CMR检查以评估LGE和室壁运动,进行表型分层。
  • LGE+/H+表型患者应加强监测和干预。
  • LGE范围可用于识别高危患者,尤其LVEF保留者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Non-dilated left ventricular cardiomyopathy (NDLVC), characterised by non-ischaemic scar/fatty replacement or isolated systolic dysfunction without dilatation, lacks validated risk stratification tools. We aimed to define cardiac magnetic resonance (CMR)-based phenotypes and evaluate their association with clinical outcomes. METHODS: In 515 patients with NDLVC (mean age 45 (16) years), three phenotypes were classified by CMR: late gadolinium enhancement (LGE+)/H- (LGE with preserved left ventricular ejection fraction (LVEF), n=130), LGE-/H+ (hypokinesia without LGE, n=226) and LGE+/H+ (LGE with reduced LVEF, n=159). The primary endpoint was all-cause death/heart transplantation; secondary endpoints included heart failure (HF) events and malignant ventricular arrhythmia (MVA). RESULTS: Over a mean follow-up of 6.5 (1.9) years, 29 patients (5.6%) reached the primary endpoint, while 81 (15.7%) and 19 (3.7%) experienced HF and MVA, respectively. The LGE+/H+ subgroup demonstrated the highest risk for composite clinical endpoints compared with other phenotypic groups (p<0.001). Multivariable analysis identified New York Heart Association class >II (HR 3.42, 95% CI 1.58 to 7.39, p=0.002), LVEF (HR 0.91 per 1% increase, 95% CI 0.88 to 0.95, p<0.001) and LGE extent (HR 1.14 per 3% increase, 95% CI 1.07 to 1.21, p<0.001) as independent predictors of the primary endpoint, with excellent discriminative power (C-statistic 0.862). In the adjusted model, LGE extent also independently predicted HF (HR 1.11 per 3%, 95% CI 1.06 to 1.17, p<0.001). The univariable Cox regression analysis indicated LGE extent was significantly associated with MVA (HR 1.12 per 3%, 95% CI 1.02 to 1.23, p=0.021). CONCLUSION: CMR phenotyping enables risk stratification in NDLVC. LGE extent provides an objective marker to identify high-risk patients-even with preserved ejection fraction-supporting its integration into routine evaluation.

来源:Heart,查看原文。版权归原作者所有。

引用

  1. Jiang M, Zhou W, Qiao HY, et al. Phenotypic stratification and prognostic value of cardiac magnetic resonance in non-dilated left ventricular cardiomyopathy. Heart. 2026. PMID: 40819904. doi:10.1136/heartjnl-2025-326192

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。